Literature DB >> 1928538

Canine seroprevalence and the distribution of Ixodes dammini in an area of emerging Lyme disease.

P W Rand1, R P Smith, E H Lacombe.   

Abstract

This study evaluates the relative usefulness of canine serosurveys to predict risk of exposure in an area of emerging Lyme disease by comparing the distribution of canine seroprevalence with that of vector ticks. From 16 veterinary clinics throughout the State of Maine, 828 canine sera were obtained during the heartworm-testing months of April and May 1989 and measured for anti-Borrelia antibodies by enzyme-linked immunosorbent assay. In the same year, 1605 ticks, including 585 Ixodes dammini, were collected from pets, humans, small mammals, and deer. Thirty-six dogs were seropositive, 28 of which had not traveled to endemic areas. Eighty-nine percent of all seropositive dogs were from towns within 20 miles (32 km) of the coast; the great majority lived within 5 miles (8 km) of tidewater (odds ratio =4.45, P = .002). Positivity varied from 17% in a southern coastal clinic to 0% in four northern clinics. Of 585 I. dammini identified, all but 5 (99.1%) were also from towns within 20 miles of the coast. Comparison of I. dammini submissions with those of another commonly found tick, Ixodes cookei, corroborated this predominantly coastal distribution. Canine seropositivity generally coincided with this coastal range. These data predicted areas of risk for human Lyme disease, although the prevalence of reported cases remained low.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928538      PMCID: PMC1405313          DOI: 10.2105/ajph.81.10.1331

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  16 in total

Review 1.  Serologic diagnosis of Lyme disease.

Authors:  L A Magnarelli
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  Pictorial key to the adults of hard ticks, family Ixodidae (Ixodida: Ixodoidea), east of the Mississippi River.

Authors:  J E Keirans; T R Litwak
Journal:  J Med Entomol       Date:  1989-09       Impact factor: 2.278

3.  Human babesiosis on Nantucket Island, USA: description of the vector, Ixodes (Ixodes) dammini, n. sp. (Acarina: Ixodidae).

Authors:  A Spielman; C M Clifford; J Piesman; M D Corwin
Journal:  J Med Entomol       Date:  1979-03-23       Impact factor: 2.278

4.  Greater risk of Borrelia burgdorferi infection in dogs than in people.

Authors:  T R Eng; M L Wilson; A Spielman; C C Lastavica
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

5.  Antibodies to Borrelia burgdorferi in dogs in North Carolina.

Authors:  R T Greene; J F Levine; E B Breitschwerdt; H A Berkhoff
Journal:  Am J Vet Res       Date:  1988-04       Impact factor: 1.156

6.  Mandatory reporting of infectious diseases by clinicians.

Authors:  T L Chorba; R L Berkelman; S K Safford; N P Gibbs; H F Hull
Journal:  JAMA       Date:  1989-12-01       Impact factor: 56.272

7.  Comparison of indirect immunofluorescent-antibody assay, enzyme-linked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs.

Authors:  J Lindenmayer; M Weber; J Bryant; E Marquez; A Onderdonk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Clinical and epizootiologic characteristics of dogs seropositive for Borrelia burgdorferi in Texas: 110 cases (1988).

Authors:  N D Cohen; C N Carter; M A Thomas; A B Angulo; A K Eugster
Journal:  J Am Vet Med Assoc       Date:  1990-10-01       Impact factor: 1.936

9.  The genus Ixodes in the United States: a scanning electron microscope study and key to the adults.

Authors:  J E Keirans; C M Clifford
Journal:  J Med Entomol Suppl       Date:  1978-07-20

10.  Borreliosis in dogs from southern Connecticut.

Authors:  L A Magnarelli; J F Anderson; A F Kaufmann; L L Lieberman; G D Whitney
Journal:  J Am Vet Med Assoc       Date:  1985-05-01       Impact factor: 1.936

View more
  10 in total

1.  Serological confirmation of Borrelia burgdorferi infection in dogs in the Czech Republic.

Authors:  K Pejchalová; A Zákovská; K Fucík; P Schánilec
Journal:  Vet Res Commun       Date:  2006-04       Impact factor: 2.459

2.  Evaluation of dogs as sero-indicators of the geographic distribution of Lyme borreliosis in British Columbia.

Authors:  S Banerjee; C Stephen; K Fernando; S Coffey; M Dong
Journal:  Can Vet J       Date:  1996-03       Impact factor: 1.008

3.  Borrelia miyamotoi, Other Vector-Borne Agents in Cat Blood and Ticks in Eastern Maryland.

Authors:  Avery B Shannon; Renee Rucinsky; Holly D Gaff; R Jory Brinkerhoff
Journal:  Ecohealth       Date:  2017-09-06       Impact factor: 3.184

4.  The search for Ixodes dammini and Borrelia burgdorferi in Nova Scotia.

Authors:  C R Bell; H B Specht; B A Coombs
Journal:  Can J Infect Dis       Date:  1992-09

5.  Elevated Lyme disease seroprevalence among dogs in a nonendemic county: harbinger or artifact?

Authors:  Katharine Millen; Kiersten J Kugeler; Alison F Hinckley; Elisabeth W Lawaczeck; Paul S Mead
Journal:  Vector Borne Zoonotic Dis       Date:  2013-02-19       Impact factor: 2.133

6.  Seroepidemiological survey for Borrelia burgdorferi (Lyme disease) in dogs from northwestern of Spain.

Authors:  S Delgado; P Cármenes
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

7.  Multitarget test for emerging Lyme disease and anaplasmosis in a serosurvey of dogs, Maine, USA.

Authors:  Peter W Rand; Eleanor H Lacombe; Susan P Elias; Bruce K Cahill; Charles B Lubelczyk; Robert P Smith
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

8.  Antibody testing and Lyme disease risk.

Authors:  Elizabeth G Stone; Eleanor H Lacombe; Peter W Rand
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

9.  Under-Detection of Lyme Disease in Canada.

Authors:  Vett K Lloyd; Ralph G Hawkins
Journal:  Healthcare (Basel)       Date:  2018-10-15

Review 10.  Vaccination against Lyme disease: past, present, and future.

Authors:  Monica E Embers; Sukanya Narasimhan
Journal:  Front Cell Infect Microbiol       Date:  2013-02-12       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.